Correlation
The correlation between RARE and IOVA is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
RARE vs. IOVA
Compare and contrast key facts about Ultragenyx Pharmaceutical Inc. (RARE) and Iovance Biotherapeutics, Inc. (IOVA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RARE or IOVA.
Performance
RARE vs. IOVA - Performance Comparison
Loading data...
Key characteristics
RARE:
-0.28
IOVA:
-0.92
RARE:
-0.17
IOVA:
-1.83
RARE:
0.98
IOVA:
0.76
RARE:
-0.16
IOVA:
-0.83
RARE:
-0.56
IOVA:
-1.80
RARE:
24.02%
IOVA:
45.46%
RARE:
43.61%
IOVA:
87.66%
RARE:
-82.49%
IOVA:
-99.37%
RARE:
-80.82%
IOVA:
-98.90%
Fundamentals
RARE:
$3.31B
IOVA:
$611.10M
RARE:
-$5.94
IOVA:
-$1.22
RARE:
-0.24
IOVA:
0.00
RARE:
5.61
IOVA:
2.87
RARE:
22.96
IOVA:
0.80
RARE:
$590.69M
IOVA:
$212.68M
RARE:
$493.97M
IOVA:
$40.83M
RARE:
-$449.90M
IOVA:
-$365.16M
Returns By Period
In the year-to-date period, RARE achieves a -19.11% return, which is significantly higher than IOVA's -76.35% return. Over the past 10 years, RARE has outperformed IOVA with an annualized return of -9.52%, while IOVA has yielded a comparatively lower -16.58% annualized return.
RARE
-19.11%
-12.70%
-28.55%
-11.95%
-10.14%
-13.05%
-9.52%
IOVA
-76.35%
-51.25%
-81.22%
-80.56%
-36.24%
-44.11%
-16.58%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
RARE vs. IOVA — Risk-Adjusted Performance Rank
RARE
IOVA
RARE vs. IOVA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Ultragenyx Pharmaceutical Inc. (RARE) and Iovance Biotherapeutics, Inc. (IOVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
RARE vs. IOVA - Dividend Comparison
Neither RARE nor IOVA has paid dividends to shareholders.
Drawdowns
RARE vs. IOVA - Drawdown Comparison
The maximum RARE drawdown since its inception was -82.49%, smaller than the maximum IOVA drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for RARE and IOVA.
Loading data...
Volatility
RARE vs. IOVA - Volatility Comparison
The current volatility for Ultragenyx Pharmaceutical Inc. (RARE) is 16.64%, while Iovance Biotherapeutics, Inc. (IOVA) has a volatility of 64.51%. This indicates that RARE experiences smaller price fluctuations and is considered to be less risky than IOVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
RARE vs. IOVA - Financials Comparison
This section allows you to compare key financial metrics between Ultragenyx Pharmaceutical Inc. and Iovance Biotherapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities